Pharmacokinetics, Immunogenicity and Safety Study for SHR-1309 Injection and Perjeta® in Healthy Chinese Male Volunteers

• Main Authors: Yingzi Cui (Author), Dongyang Cui (Author), Xinran Ren (Author), Xuesong Chen (Author), Guangwen Liu (Author), Zhengzhi Liu (Author), Yanli Wang (Author), Xinyao Qu (Author), Yicheng Zhao (Author), Haimiao Yang (Author)
• Format: Book
• Published: Frontiers Media S.A., 2021-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Objectives: Pertuzumab is a monoclonal antibody for the treatment of breast cancer. The aim of this study was to compare the pharmacokinetics, immunogenicity and safety of the test preparation SHR-1309 injecta and the reference preparation Perjeta® in healthy Chinese male subjects.Methods: In this r...